Repolarization of the cardiac action potential. Does an increase in repolarization capacity constitute a new anti‐arrhythmic principle?
Author:
- 3 February 2010
- journal article
- Published by Wiley in Acta Physiologica
- Vol. 198 (s676) , 1-48
Abstract
The cardiac action potential can be divided into five distinct phases designated phases 0–4. The exact shape of the action potential comes about primarily as an orchestrated function of ion channels. The present review will give an overview of ion channels involved in generating the cardiac action potential with special emphasis on potassium channels involved in phase 3 repolarization. In humans, these channels are primarily Kv11.1 (hERG1), Kv7.1 (KCNQ1) and Kir2.1 (KCNJ2) being the responsible α‐subunits for conductingIKr,IKsandIK1. An account will be given about molecular components, biophysical properties, regulation, interaction with other proteins and involvement in diseases. Both loss and gain of function of these currents are associated with different arrhythmogenic diseases. The second part of this review will therefore elucidate arrhythmias and subsequently focus on newly developed chemical entities having the ability to increase the activity ofIKr,IKsandIK1. An evaluation will be given addressing the possibility that this novel class of compounds have the ability to constitute a new anti‐arrhythmic principle. Experimental evidence fromin vitro,ex vivoandin vivosettings will be included. Furthermore, conceptual differences between the short QT syndrome andIKractivation will be accounted for.Keywords
This publication has 395 references indexed in Scilit:
- Energetic performance is improved by specific activation of K+ fluxes through KCa channels in heart mitochondriaBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- hERG1a/1b heteromeric currents exhibit amplified attenuation of inactivation in variant 1 short QT syndromeBiochemical and Biophysical Research Communications, 2009
- Mutation in the S3 segment of KCNQ1 results in familial lone atrial fibrillationHeart Rhythm, 2009
- Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndromeHeart Rhythm, 2008
- Recurrent intrauterine fetal loss due to near absence of HERG: Clinical and functional characterization of a homozygous nonsense HERG Q1070X mutationHeart Rhythm, 2008
- Early electrical remodeling in rabbit pulmonary vein results from trafficking of intracellular SK2 channels to membrane sitesCardiovascular Research, 2007
- hERG K+ channel blockade by the antipsychotic drug thioridazine: An obligatory role for the S6 helix residue F656Biochemical and Biophysical Research Communications, 2006
- Frequency-dependent modulation of KCNQ1 and HERG1 potassium channelsBiochemical and Biophysical Research Communications, 2006
- hKCNE4 inhibits the hKCNQ1 potassium current without affecting the activation kineticsBiochemical and Biophysical Research Communications, 2005
- A Classification of Antiarrhythmic Actions Reassessed After a Decade of New DrugsThe Journal of Clinical Pharmacology, 1984